corneal densitometry in patients Amiodaron induced keratopathy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00008890

Enrollment

100

Registered

2015-07-14

Start date

2015-06-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H18.9

Interventions

Group 1: In Patients under Amiodaron Treatment , we measure the densitometrie with the Pentacam ´(occulus Pentacam)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: adult, Ammiodaron Treatment

Exclusion criteria

Exclusion criteria: history of corneal disease pregnancy renal or liver disease

Design outcomes

Primary

Measure	Time frame
corneal densitometry The präsens of corneal deposits	—

Secondary

Measure	Time frame
correlation with Treatment duration and dose	—

Countries

Germany

Contacts

Public ContactMaged Alnawaiseh

Universitäts-Augenklinik Münster

maged.alnawaiseh@ukmuenster.de02518356001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026